hr

Hot Keywords
non-alcoholic fatty liver disease epidemiology microenvironment nonalcoholic steatohepatitis transplantation cholangiocarcinoma direct-acting antiviral immunotherapy hepatitis B hepatitis C liver resection imaging cancer stem cell diagnosis gene cirrhosis biomarker recurrence

Top

Chair(s)

  • Giuliano Ramadori

    Professor of medicine, Gastroenterology and Endocrinology, University Medical Center Göttingen, Göttingen, Germany. Executive Chief Editor of Hepatoma Research.

  • Alessandro Ortenzi

    Doctor, Phase 1 Clinical Trials QA Coordinator - Ospedali Riuniti Ancona - Umberto I G.M. Lancisi G. Salesi, Clinical Trial Quality Assurance, United Hospitals of Ancona, Ancona, Marches, Italy.

Speakers

  • David H Van Thiel

    Professor of medicine, a former president of the American Association for the Study of Liver Disease, Gastroenterologist in Berwyn, Rush University Medical Center, Berwyn, Illinois, USA.
    Topic: The use of systemic therapy for HCC relapse post transplantation

  • Guido Gerken

    Director emeritus of the Department of Gastroenterology and Hepatology, University of Essen, Essen, Germany.
    Ethics committee of the European Association for the Study of the Liver (EASL). Associate Editor of Hepatoma Research.
    Topic: How to screen and diagnose liver function in patients with chronic liver disease including liver cirrhosis

  • Fabio Farinati

    Director Gastroenterology, Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy. Associate Editor of Hepatoma Research.
    Topic: "Special" problems in the modern treatment of HCC in cirrhotic patients

  • Michael Montemurro

    Consultant Medical Oncologist, Department of Oncology & London Sarcoma Service, University College London Hospitals UCLH NHS, London, UK.
    Topic: Therpaeutic aims of the oncologist: between cancer control and quality of life

  • Alessandro Ortenzi

    Doctor, Phase 1 Clinical Trials QA Coordinator - Ospedali Riuniti Ancona - Umberto I G.M. Lancisi G. Salesi, Clinical Trial Quality Assurance, United Hospitals of Ancona, Ancona, Marches, Italy.
    Topic: Preventive actions for safety in biological therapies

Programme

      Time(Italy)
      Speakers
      Topic
      13:00-13:10
      Giuliano Ramadori & Alessandro Ortenzi
      Welcome speech
      13:10-13:30
      Alessandro Ortenzi
      Preventive actions for safety in biological therapies
      13:30-14:00
      Guido Gerken
      How to screen and diagnose liver function in patients with chronic liver disease including liver cirrhosis
      14:00-14:30
      David H Van Thiel
      The use of systemic therapy for HCC relapse post transplantation
      14:30-15:00
      Fabio Farinati
      "Special" problems in the modern treatment of HCC in cirrhotic patients
      15:00-15:30
      Michael Montemurro
      Therpaeutic aims of the oncologist: between cancer control and quality of life
      15:30-15:50
      Giuliano Ramadori & Alessandro Ortenzi
      Conclusion and discussion

Moments

Presentation

  • Alessandro Ortenzi
    Preventive actions for safety in biological therapies
  • Guido Gerken
    How to screen and diagnose liver function in patients with chronic liver disease including liver cirrhosis
  • David H Van Thiel
    The use of systemic therapy for HCC relapse post transplantation
  • Fabio Farinati
    "Special" problems in the modern treatment of HCC in cirrhotic patients
  • Michael Montemurro
    Therpaeutic aims of the oncologist: between cancer control and quality of life
  • Conclusion and discussion
© 2016-2021 OAE Publishing Inc., except certain content provided by third parties